Our Illinois GLP-1 program includes regular virtual check-ins with our medical team to track your progress, manage any side effects, and adjust your personalized plan
Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson's disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: the 'Exenatide-PD3' study
GLP-1 drugs are essentially the next generation of that playbook: powerful new drugs that are like supercharged versions of our own hunger-checking hormones, which can help athletes get lean
When we ensure that every patient not only receives their medicines but also feels confident theyre right, were not just supporting recovery were nurturing hope, clarity, and confidence in better health